ETF Holdings Breakdown of OKUR

OKUR institutional holdings

The adjusted close for OKUR on 2025-11-12 was 3.08

The following institutional investment holdings of OKUR have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	7,828	USD 24,110	3.08
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	7,828 0.3%	USD 24,110 -2.6%	3.08
Total =		15,656	USD 48,220

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with OKUR

OnKure Therapeutics (NASDAQ:OKUR) Given “Buy” Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of OnKure Therapeutics (NASDAQ:OKUR – Free Report) in a research report report published on Tuesday morning,Benzinga reports. They currently have a $34.00 price target on the stock. Other equities research analysts have also issued reports about the company. Evercore ISI initiated coverage on OnKure Therapeutics in a […] - 2025-08-27 03:06:43

OnKure Therapeutics, Inc. (NASDAQ:OKUR) Receives Consensus Recommendation of “Buy” from Analysts

Shares of OnKure Therapeutics, Inc. (NASDAQ:OKUR – Get Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year […] - 2025-06-24 02:52:59

OnKure Therapeutics (NASDAQ:OKUR) Receives $32.33 Consensus PT from Analysts

OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month target […] - 2025-05-28 02:50:54

OMERS ADMINISTRATION Corp Invests $104,000 in OnKure Therapeutics (NASDAQ:OKUR)

OMERS ADMINISTRATION Corp bought a new position in OnKure Therapeutics (NASDAQ:OKUR – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,100 shares of the company’s stock, valued at approximately $104,000. OMERS ADMINISTRATION Corp owned about 0.36% of OnKure […] - 2025-05-21 05:48:48

Cormorant Asset Management, Lp Sells 1,813,439 Shares of OnKure Therapeutics (NASDAQ:OKUR) Stock

OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) major shareholder Cormorant Asset Management, Lp sold 1,813,439 shares of the firm’s stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $1.85, for a total value of $3,354,862.15. The transaction was disclosed in a filing with the SEC, which is […] - 2025-05-21 05:04:53

OnKure Therapeutics (NASDAQ:OKUR) and Anebulo Pharmaceuticals (NASDAQ:ANEB) Financial Contrast

OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) and Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk. Profitability This table compares OnKure Therapeutics and […] - 2025-05-08 02:52:49

Renaissance Technologies LLC Invests $408,000 in OnKure Therapeutics (NASDAQ:OKUR)

Renaissance Technologies LLC acquired a new stake in OnKure Therapeutics (NASDAQ:OKUR – Free Report) during the 4th quarter, Holdings Channel reports. The fund acquired 47,450 shares of the company’s stock, valued at approximately $408,000. A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in OKUR. Highbridge […] - 2025-05-05 04:40:51

XTX Topco Ltd Makes New Investment in OnKure Therapeutics (NASDAQ:OKUR)

XTX Topco Ltd bought a new position in shares of OnKure Therapeutics (NASDAQ:OKUR – Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 18,633 shares of the company’s stock, valued at approximately $160,000. XTX Topco Ltd owned 0.56% of OnKure Therapeutics at the […] - 2025-04-29 05:01:02

Back to Listing

Disclaimer